These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24145760)

  • 1. Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas.
    Oehme I; Lodrini M; Brady NR; Witt O
    Autophagy; 2013 Dec; 9(12):2163-5. PubMed ID: 24145760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase 10 promotes autophagy-mediated cell survival.
    Oehme I; Linke JP; Böck BC; Milde T; Lodrini M; Hartenstein B; Wiegand I; Eckert C; Roth W; Kool M; Kaden S; Gröne HJ; Schulte JH; Lindner S; Hamacher-Brady A; Brady NR; Deubzer HE; Witt O
    Proc Natl Acad Sci U S A; 2013 Jul; 110(28):E2592-601. PubMed ID: 23801752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance.
    Ridinger J; Koeneke E; Kolbinger FR; Koerholz K; Mahboobi S; Hellweg L; Gunkel N; Miller AK; Peterziel H; Schmezer P; Hamacher-Brady A; Witt O; Oehme I
    Sci Rep; 2018 Jul; 8(1):10039. PubMed ID: 29968769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma.
    Lautz TB; Naiditch JA; Clark S; Chu F; Madonna MB
    J Pediatr Surg; 2012 Jun; 47(6):1267-71. PubMed ID: 22703804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells.
    Francisco R; Pérez-Perarnau A; Cortés C; Gil J; Tauler A; Ambrosio S
    Cancer Lett; 2012 May; 318(1):42-52. PubMed ID: 22186300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
    Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mobility group box 1-mediated autophagy promotes neuroblastoma cell chemoresistance.
    Wang L; Zhang H; Sun M; Yin Z; Qian J
    Oncol Rep; 2015 Dec; 34(6):2969-76. PubMed ID: 26397184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy is associated with chemoresistance in neuroblastoma.
    Belounis A; Nyalendo C; Le Gall R; Imbriglio TV; Mahma M; Teira P; Beaunoyer M; Cournoyer S; Haddad E; Vassal G; Sartelet H
    BMC Cancer; 2016 Nov; 16(1):891. PubMed ID: 27846885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase 8 in neuroblastoma tumorigenesis.
    Oehme I; Deubzer HE; Wegener D; Pickert D; Linke JP; Hero B; Kopp-Schneider A; Westermann F; Ulrich SM; von Deimling A; Fischer M; Witt O
    Clin Cancer Res; 2009 Jan; 15(1):91-9. PubMed ID: 19118036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
    Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma.
    de Ruijter AJ; Meinsma RJ; Bosma P; Kemp S; Caron HN; van Kuilenburg AB
    Exp Cell Res; 2005 Oct; 309(2):451-67. PubMed ID: 16084510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and potential clinical utility of biomarkers for HDAC inhibitors.
    Shi B; Xu W
    Drug Discov Ther; 2013 Aug; 7(4):129-36. PubMed ID: 24071574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells.
    de Ruijter AJ; Kemp S; Kramer G; Meinsma RJ; Kaufmann JO; Caron HN; van Kuilenburg AB
    Biochem Pharmacol; 2004 Oct; 68(7):1279-88. PubMed ID: 15345317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Autophagy Induction After HDAC Inhibitor Treatment in Leukemic Cells.
    Göder A; Mahendrarajah N; Krämer OH
    Methods Mol Biol; 2017; 1510():3-10. PubMed ID: 27761809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of HDAC8 and investigational inhibitors in neuroblastoma.
    Oehme I; Deubzer HE; Lodrini M; Milde T; Witt O
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1605-17. PubMed ID: 19780707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histones and lung cancer: Are the histone deacetylases a promising therapeutic target?
    Petta V; Gkiozos I; Strimpakos A; Syrigos K
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):935-52. PubMed ID: 24036844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region.
    Flahaut M; Mühlethaler-Mottet A; Martinet D; Fattet S; Bourloud KB; Auderset K; Meier R; Schmutz NB; Delattre O; Joseph JM; Gross N
    Genes Chromosomes Cancer; 2006 May; 45(5):495-508. PubMed ID: 16450357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy.
    Carew JS; Giles FJ; Nawrocki ST
    Cancer Lett; 2008 Sep; 269(1):7-17. PubMed ID: 18462867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.
    Frew AJ; Johnstone RW; Bolden JE
    Cancer Lett; 2009 Aug; 280(2):125-33. PubMed ID: 19359091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.